[Purpura fulminans, venous thrombosis and constitutional thrombophilia in an infant]. 2013

F Fadil, and F Elfatoiki, and K Mortaji, and F Lasry, and M Itri, and K Khadir, and H Benchikhi, and N Sarbati, and S Nadifi
Service de pédiatrie 3, hôpital d'enfant, CHU Ibn Rochd, Casablanca, Maroc. fz.fadi@gmail.com

The association of idiopathic purpura fulminans (PF) and venous thrombosis (VT) seldom reveals constitutional thrombophilia in an infant. We report a case of PF in an 18-month-old infant. Laboratory tests showed disseminated intravascular coagulation (DIVC) with normal rates of C and S proteins and antithrombin. The echo-Doppler examination conveyed venous thrombosis of the lower limbs, while the genetic study showed heterozygous mutation of Factor II (G 20210A). Precocious and multidisciplinary management included frozen fresh plasma supplementation and necrosectomy with skin grafts. The diagnosis and therapeutic problems posed by PF combined with deep venous thrombosis are discussed.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D009336 Necrosis The death of cells in an organ or tissue due to disease, injury or failure of the blood supply.
D011516 Prothrombin A plasma protein that is the inactive precursor of thrombin. It is converted to thrombin by a prothrombin activator complex consisting of factor Xa, factor V, phospholipid, and calcium ions. Deficiency of prothrombin leads to hypoprothrombinemia. Coagulation Factor II,Factor II,Blood Coagulation Factor II,Differentiation Reversal Factor,Factor II, Coagulation,Factor, Differentiation Reversal,II, Coagulation Factor
D003299 Cooperative Behavior The interaction of two or more persons or organizations directed toward a common goal which is mutually beneficial. An act or instance of working or acting together for a common purpose or benefit, i.e., joint action. (From Random House Dictionary Unabridged, 2d ed) Compliant Behavior,Behavior, Compliant,Behavior, Cooperative,Compliant Behaviors,Cooperative Behaviors
D004211 Disseminated Intravascular Coagulation A disorder characterized by procoagulant substances entering the general circulation causing a systemic thrombotic process. The activation of the clotting mechanism may arise from any of a number of disorders. A majority of the patients manifest skin lesions, sometimes leading to PURPURA FULMINANS. Consumption Coagulopathy,Coagulation, Disseminated Intravascular,Disseminated Coagulation, Intravascular,Intravascular Coagulation, Disseminated,Intravascular Disseminated Coagulation,Coagulation, Intravascular Disseminated,Coagulations, Disseminated Intravascular,Coagulations, Intravascular Disseminated,Coagulopathies, Consumption,Coagulopathy, Consumption,Consumption Coagulopathies,Disseminated Coagulations, Intravascular,Disseminated Intravascular Coagulations,Intravascular Coagulations, Disseminated,Intravascular Disseminated Coagulations
D004252 DNA Mutational Analysis Biochemical identification of mutational changes in a nucleotide sequence. Mutational Analysis, DNA,Analysis, DNA Mutational,Analyses, DNA Mutational,DNA Mutational Analyses,Mutational Analyses, DNA
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D005602 France A country in western Europe bordered by the Atlantic Ocean, the English Channel, the Mediterranean Sea, and the countries of Belgium, Germany, Italy, Spain, Switzerland, the principalities of Andorra and Monaco, and by the duchy of Luxembourg. Its capital is Paris. Corsica,Saint Pierre and Miquelon,Miquelon and Saint Pierre,Miquelon and St. Pierre,St. Pierre and Miquelon
D006580 Genetic Carrier Screening Identification of individuals who are heterozygous at a GENETIC LOCUS for a recessive PHENOTYPE. Carriers, Genetic, Detection,Genetic Carriers, Detection,Heterozygote Detection,Carrier Detection, Genetic,Detection, Genetic Carrier,Genetic Carrier Detection,Heterozygote Screening,Carrier Screening, Genetic,Detection, Heterozygote,Screening, Genetic Carrier,Screening, Heterozygote,Screenings, Genetic Carrier

Related Publications

F Fadil, and F Elfatoiki, and K Mortaji, and F Lasry, and M Itri, and K Khadir, and H Benchikhi, and N Sarbati, and S Nadifi
January 1968, Acta paediatrica Belgica,
F Fadil, and F Elfatoiki, and K Mortaji, and F Lasry, and M Itri, and K Khadir, and H Benchikhi, and N Sarbati, and S Nadifi
January 1965, Sangre,
F Fadil, and F Elfatoiki, and K Mortaji, and F Lasry, and M Itri, and K Khadir, and H Benchikhi, and N Sarbati, and S Nadifi
August 2013, BMJ case reports,
F Fadil, and F Elfatoiki, and K Mortaji, and F Lasry, and M Itri, and K Khadir, and H Benchikhi, and N Sarbati, and S Nadifi
November 2005, Seminars in vascular medicine,
F Fadil, and F Elfatoiki, and K Mortaji, and F Lasry, and M Itri, and K Khadir, and H Benchikhi, and N Sarbati, and S Nadifi
December 2005, Seminars in thrombosis and hemostasis,
F Fadil, and F Elfatoiki, and K Mortaji, and F Lasry, and M Itri, and K Khadir, and H Benchikhi, and N Sarbati, and S Nadifi
November 1990, The Journal of pediatrics,
F Fadil, and F Elfatoiki, and K Mortaji, and F Lasry, and M Itri, and K Khadir, and H Benchikhi, and N Sarbati, and S Nadifi
January 1986, Pediatric infectious disease,
F Fadil, and F Elfatoiki, and K Mortaji, and F Lasry, and M Itri, and K Khadir, and H Benchikhi, and N Sarbati, and S Nadifi
December 2017, The New England journal of medicine,
F Fadil, and F Elfatoiki, and K Mortaji, and F Lasry, and M Itri, and K Khadir, and H Benchikhi, and N Sarbati, and S Nadifi
December 2017, The New England journal of medicine,
F Fadil, and F Elfatoiki, and K Mortaji, and F Lasry, and M Itri, and K Khadir, and H Benchikhi, and N Sarbati, and S Nadifi
September 2017, The New England journal of medicine,
Copied contents to your clipboard!